APPENDIXES - AHRQ Effective Health Care Program

More documents

Recommendations

Info

Table C43. Association between physician specialty and patient outcomes (continued) C107 Reference Design Vorton, 2004 154 Survey Data Source Population 676 participating in national meetings general practitioners 546 completed questionnaire Analysis Risk Adjustment Logistic regression Patient age, sex, comorbidity, physician characteristics Specialty Outcomes P Values Radiation oncologists Urologists Radiation oncologists Urologists Radiation oncologists Urologists Radiation oncologists Urologists Radiation oncologists Urologists Radiation oncologists Urologists Radiation oncologists Urologists Radiation oncologists Urologists Physician sex Males Females Ages physicians vs. young Physician sex Physician place to work Physician age Physician sex Physician place to work Radical prostatectomy underused 16% 51% Use at about the right rate 16% 51% External beam radiation overused 13% 37% External beam radiation underused 50% 5% Use at about the right rate 35% 51% Brachytherapy overused 26% 30% Brachytherapy underused 44% 27% Use at about the right rate 20% 21% Referring elderly patient with PC to a specialist Odds ratio 0.44 1 Non curative approach (hormone therapy and watchful waiting) Odds ratio 1.1 (1.021.09) Not significant Not significant Treatments of prostate cancer in elderly patients Surgical treatment vs. Hormone therapy Not significant Not significant Not significant
Figure C7. Percentage of responses by family physicians and general internists to the question: “Do you recommend the following for prostate cancer screening for patients 50 years old and older?” (Kim, 2002) 139 100 90 * % of positive responses 80 70 60 50 40 30 * * 20 10 * 0 DRE PSA No screening >60 years Age not a criteria Family physician General internist DRE = digital rectal examination; PSA = prostate specific antigen * significant differences at 95% CI C108
Page 1 and 2:
APPENDIXES
Page 3 and 4:
Appendix A: Search Strategy (contin
Page 6 and 7:
Appendix C: Evidence Tables and Fig
Page 8 and 9:
Table C1. Disease specific mortalit
Page 10 and 11:
Table C2. Biochemical progression/r
Page 12 and 13:
Table C2. Biochemical progression/r
Page 14 and 15:
Table C4. Incidence of distant meta
Page 16 and 17:
Figure C2. Diseasespecific surviv
Page 18 and 19:
Table C8. Outcomes after cryosurgic
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Table C10. Comparative effectivenes
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Table C13. Perioperative and pathol
Page 32 and 33:
Figure C4. Comparative studies of t
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Table C17. Clinical outcomes after
Page 44 and 45:
Table C19. Late toxicity outcomes a
Page 46 and 47:
Table C20. Patient outcomes after h
Page 48 and 49:
Table C21. Proton radiation for loc
Page 50 and 51:
Table C23. Adjusted percentage dist
Page 52 and 53:
Table C25. QOL studies of treatment
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Figure C6. Search strategy Database
Page 62 and 63: Table C27. Quality (% of maximum po
Page 64 and 65: Table C29. Geographic variations in
Page 84 and 85: Table C31. Association between hosp
Page 94 and 95: Table C36. Association between surg
Page 104 and 105: Table C41. Sampling sources of stud
Page 106 and 107: Table C43. Association between phys
Page 114 and 115: Figure C8. Percentage of responses
Page 120 and 121: Table C44. Variability in managemen
Page 122 and 123: Table C44. Variability in managemen
Page 124 and 125: Table C45. Association between prov
Page 126 and 127: Table C45. Association between prov
Page 132 and 133: Table C47. Distribution of urologis
Page 134 and 135: Table C49. Significant geographic d
Page 136 and 137: Figure C14. Distribution of radiati
Page 138 and 139: Figure C16. Ratio* of radiation onc
Page 142 and 143: Figure C19. Geographic variations i
Page 144 and 145: Figure C20. Incidence of prostate c
Page 148 and 149: Table C55. Incidence of localized p
Page 150 and 151: Figure C21. Percentage of patients
Page 154 and 155: Table C62. Significant variations i
Page 162 and 163:
Table C66. Geographic variations in
Page 164 and 165:
Figure C29. Length of stay in hospi
Page 166 and 167:
Figure C30. Hospital charges for ra
Page 168 and 169:
Table C73. Geographic differences i
Page 170 and 171:
Figure C31. Mortality from prostate
Page 172 and 173:
Figure C33. Difference in surgery
Page 174 and 175:
Figure C35. Relative risk of surger
Page 176 and 177:
Figure C37. Difference in surgery r
Page 178 and 179:
Figure C39. Difference in surgery r
Page 180 and 181:
Figure C41. Difference in length of
Page 182 and 183:
Figure C43. Difference in rates of
Page 184 and 185:
Table C76. Odds ratio and attributa
Page 186 and 187:
Table C78. Odds ratio of outcomes,
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Appendix D: List of Excluded Studie
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272:
Page 275 and 276:
Appendix E: Sample Abstraction Form
Page 277 and 278:
Page 279 and 280:
show all

APPENDIXES - AHRQ Effective Health Care Program

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?